Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2018	12-2017	12-2016	12-2015	12-2014
Assets
Current Assets
Cash & Cash Equivalents	20,663	93,543	21,626	185,707	35,789
Marketable Securities	51,199	0	N/A	N/A	88,340
Receivables	N/A	100	275	6,483	3,313
Inventories	N/A	N/A	N/A	3,717	N/A
Other current assets	0	0	33,295	0	0
TOTAL	$76,102	$95,046	$57,435	$201,394	$132,065

Non-Current Assets
PPE Net	2,269	6,467	14,212	21,915	14,502
Investments And Advances	7,428	10,551	0	0	0
Intangibles	0	0	0	10,960	11,330
Other Non-Current Assets	2,744	5,262	9,836	611	609
TOTAL	$12,441	$22,280	$24,048	$33,486	$26,441

Total Assets	$88,543	$117,326	$81,483	$234,880	$158,506

Liabilities
Current Liabilities
Short Term Debt	N/A	N/A	N/A	N/A	13,315
Accounts payable and accrued liabilities	13,677	17,606	28,670	52,082	37,236
Other current liabilities	1,118	2,171	59,552	1,527	1,285
TOTAL	$14,795	$19,777	$88,222	$103,746	$111,111

Non-Current Liabilities
Long Term Debt	14,873	N/A	216,861	257,655	106,687
Deferred Revenues	N/A	N/A	N/A	50,137	59,275
Other Non-Current Liabilities	56	2,425	29,298	4,995	6,938
TOTAL	$14,929	$1,265	$244,381	$315,062	$149,535

Total Liabilities	$29,724	$21,042	$332,603	$418,808	$260,646

Shareholders' Equity
Shares Outstanding, K	13,343	13,343	13,057	11,606	10,693
Common Shares	1,334	1,334	1,302	1,159	1,067
Retained earnings	-523,277	-482,771	-954,799	-802,232	-655,170
Other shareholders' equity	-9	0	0	0	-74
TOTAL	$58,819	$96,284	$-251,120	$-183,928	$-102,140

Total Liabilities And Equity	$88,543	$117,326	$81,483	$234,880	$158,506